Blueberries Medical Corp. BBRRF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -37.32% | -18.96% | -38.10% | -42.06% | 1.70% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -37.32% | -18.96% | -38.10% | -42.06% | 1.70% |
| Cost of Revenue | -72.22% | -46.58% | -52.32% | -14.13% | -24.76% |
| Gross Profit | 7.07% | 23.84% | -5.71% | -49.58% | 82.18% |
| SG&A Expenses | 4.41% | -74.97% | 13.73% | -20.31% | -17.02% |
| Depreciation & Amortization | -94.29% | -94.48% | -11.86% | -9.74% | -2.23% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -14.75% | -74.42% | -14.80% | -19.02% | -16.88% |
| Operating Income | 8.10% | 78.43% | -18.45% | 12.76% | 21.12% |
| Income Before Tax | -5.48% | 77.30% | -29.54% | -6.43% | 39.13% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.48% | 77.30% | -29.54% | -6.43% | 39.13% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.48% | 77.30% | -29.54% | -6.43% | 39.13% |
| EBIT | 8.10% | 78.43% | -18.45% | 12.76% | 21.12% |
| EBITDA | -4.02% | 77.87% | -23.65% | 13.22% | 23.21% |
| EPS Basic | 0.00% | 84.62% | 0.00% | 0.00% | 50.00% |
| Normalized Basic EPS | 0.00% | 75.00% | 0.00% | 0.00% | 50.00% |
| EPS Diluted | 0.00% | 84.62% | 0.00% | 0.00% | 50.00% |
| Normalized Diluted EPS | 0.00% | 75.00% | 0.00% | 0.00% | 50.00% |
| Average Basic Shares Outstanding | 0.00% | 22.11% | 35.43% | 24.07% | 24.07% |
| Average Diluted Shares Outstanding | 0.00% | 22.11% | 35.43% | 24.07% | 24.07% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |